APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 40 filers reported holding APTEVO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $106,000 | -88.3% | 180,149 | -82.4% | 0.01% | -88.3% |
| Q2 2019 | $906,000 | -1.5% | 1,021,836 | 0.0% | 0.10% | -19.5% |
| Q1 2019 | $920,000 | -29.1% | 1,021,836 | 0.0% | 0.13% | -30.4% |
| Q4 2018 | $1,298,000 | -63.8% | 1,021,836 | +44.6% | 0.18% | -60.7% |
| Q3 2018 | $3,590,000 | +38.4% | 706,613 | +35.9% | 0.47% | +77.3% |
| Q2 2018 | $2,594,000 | -58.7% | 519,894 | -72.9% | 0.26% | -60.4% |
| Q1 2018 | $6,280,000 | -9.0% | 1,920,368 | +18.0% | 0.67% | -19.1% |
| Q4 2017 | $6,903,000 | +57.0% | 1,628,053 | -15.2% | 0.82% | +70.2% |
| Q3 2017 | $4,398,000 | +10.6% | 1,920,368 | 0.0% | 0.48% | -2.6% |
| Q2 2017 | $3,975,000 | +0.5% | 1,920,368 | 0.0% | 0.50% | -20.7% |
| Q1 2017 | $3,956,000 | -15.6% | 1,920,368 | 0.0% | 0.63% | -28.8% |
| Q4 2016 | $4,686,000 | +87.8% | 1,920,368 | +97.1% | 0.88% | +59.3% |
| Q3 2016 | $2,495,000 | – | 974,492 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,021,836 | $1,298,000 | 0.18% |
| HighVista Strategies LLC | 79,568 | $101,000 | 0.09% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $62,287,000 | 0.02% |
| Spark Investment Management LLC | 135,600 | $172,000 | 0.01% |
| Park West Asset Management LLC | 165,520 | $210,000 | 0.01% |
| CSS LLC/IL | 86,727 | $110,000 | 0.01% |
| Meridian Wealth Advisors, LLC | 5,000 | $6,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 462,824 | $587,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 101,014 | $128,000 | 0.00% |
| SFMG, LLC | 15,544 | $20,000 | 0.00% |